M. Kuwana et al., Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura, BLOOD, 98(1), 2001, pp. 130-139
It was recently reported that autoreactive CD4(+) T cells to glycoprotein I
Ib-IIIa (GPIIb-IIIa) mediate antiplatelet autoantibody production in patien
ts with immune thrombocytopenic purpura (ITP). To further examine the antig
enic specificity of the GPIIb-IIIa-reactive T cells, 6 recombinant fragment
s encoding different portions of GPIIb alpha or GPIIIa were generated and t
ested for their ability to stimulate antigen-specific T-cell proliferation
and anti-GPIIb-IIIa antibody production in vitro. T cells from the peripher
al blood of 25 patients with ITP and 10 healthy donors proliferated in resp
onse to recombinant GPIIb-IIIa fragments in various combinations. The amino
-terminal portions of both GPIIb alpha and GPIIIa (IIb alpha 18-259 and III
a22-262) were frequently recognized (60% and 64%, respectively) compared wi
th other fragments (4%-28%)in patients with ITP, but this tendency was not
detected in healthy donors, In subsequent analyses in patients with ITP, T-
cell reactivities to IIb alpha 18-259 and IIIa22-262 were consistently dete
cted, whereas those to other fragments were sometimes loaf. In vitro antige
nic stimulation of peripheral blood mononuclear cells with IIb alpha 18-259
or IIIa22-262 promoted the synthesis of anti-GPIIb-IIIa antibodies in pati
ents with ITP, but not in healthy donors, Of 15 CD4(+) T-cell lines specifi
c for platelet-derived GPIIb-IIIa generated from 5 patients with ITP, 13 li
nes recognized IIb alpha 18-259, IIIa22-262, or both, T-cell lines reactive
to IIb alpha 18-259 or IIIa22-262 promoted the production of anti-GPIIb-II
Ia antibodies that were capable of binding to normal platelet surfaces, The
se results indicate that the immunodominant epitopes recognized by pathogen
ic CD4(+) T cells in patients with ITP are located within the amino-termina
l portions of both GPIIb alpha and GPIIIa. (C) 2001 by The American Society
of Hematology.